Life Sciences And Medical Technology Payment Practices: 5-Year Analysis (2020-2025)
Life Sciences and MedTech Payment Practices Improve Marginally: Scores Rise by 4.1 Points From 2020 to 2025
The Comparison
- 2020: A study of 107 companies revealed an average payment practices score of 59.0 out of 100.
- 2025: Analysis of 99 companies shows a slight increase in the average payment practices score, reaching 63.1 out of 100.
What This Means
While an improvement is evident, the 4.1-point increase between 2020 and 2025 suggests a slow pace of change in payment behaviors within the Life Sciences and Medical Technology sectors; the decrease in sample size may indicate industry consolidation or a shift in focus for data collection. This marginal progress highlights the need for businesses to actively monitor and manage their payment cycles, tools like this late payment calculator can help calculate the impact of delayed payments.
In summary, payment practices in Life Sciences and MedTech showed a minor improvement, shifting from an average score of 59.0 (out of 100) in 2020 to 63.1 in 2025.
